
Purines and Pyrimidine Derivatives
Purines have a bicyclic structure, consisting of a six-membered ring fused to a five-membered ring, both containing nitrogen atoms in key positions. Purine derivatives, such as adenine and guanine, are essential for the formation of DNA and RNA. These compounds have therapeutic applications in cancer and viral disease treatments by inhibiting cell replication. Pyrimidines, on the other hand, have a monocyclic six-membered structure with two nitrogen atoms. Their derivatives, such as cytosine, thymine, and uracil, are also essential components of DNA and RNA and are used in chemotherapy and antiviral treatments.
At CymitQuimica, we offer purine and pyrimidine derivatives for research in molecular biology, genomics, and the development of innovative therapies.
Found 8902 products of "Purines and Pyrimidine Derivatives"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Clopidogrel Open Ring Hydrochloride (methyl (S)-2-(2-chlorophenyl)-2-((2-(thiophen-2-yl)ethyl)amino) acetate, hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C15H16ClNO2S·HClColor and Shape:White Off-White SolidMolecular weight:345.03571Caffeine
CAS:Caffeine and its saltsFormula:C8H10N4O2Color and Shape:White Crystalline Powder NeedlesMolecular weight:194.08038Theophylline
CAS:Theophylline and aminophylline (excluding fenetylline) and their derivatives, salts thereof, not elsewhere specified or includedFormula:C7H8N4O2Color and Shape:White PowderMolecular weight:180.17 g/molClopidogrel Thienopyridinium Chloride (5-(1-(2-chlorophenyl)-2-methoxy-2-oxoethyl)thieno[3,2-c]pyridin-5-ium, chloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C16H13ClNO2S·ClColor and Shape:Off-White SolidMolecular weight:318.03555Clopidogrel R-Enantiomer ((R)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C15H15ClN2OSColor and Shape:White Off-White SolidMolecular weight:306.05936Febuxostat Related Compound E (2-(3-Cyano-4-propoxyphenyl)-4-methylthiazole-5-carboxylic acid)
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormula:C15H14N2O3SColor and Shape:White Fine PowderMolecular weight:302.07251Methylbenzhydrol (2-Methylbenzhydrol)
CAS:Aromatic alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives, nesoiFormula:C14H14OColor and Shape:White PowderMolecular weight:198.10447Pemetrexed Acid N-Hydroxysuccinimide Ester (2,5-dioxopyrrolidin-1-yl 4-(2-(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzoate)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormula:C19H17N5O5Color and Shape:White Off-White SolidMolecular weight:395.12297Aspirin
CAS:Ortho-acetylsalicylic acid (aspirin), its salts and estersFormula:C9H8O4Color and Shape:White Colorless SolidMolecular weight:180.04226Ondansetron Related Compound C (9-Methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C13H13NOColor and Shape:White Powder ClumpyMolecular weight:199.09971Ondansetron Hydrochloride
CAS:Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormula:C18H19N3O·HCl·2H2OColor and Shape:White Off-White PowderMolecular weight:293.15281Ondansetron Related Compound A (3-[(Dimethylamino)methyl]-9-methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one hydrochloride)
CAS:Drugs with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C16H20N2O·HClColor and Shape:White SolidMolecular weight:256.15756Ondansetron
CAS:Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure nesoiFormula:C18H19N3OColor and Shape:White Off-White PowderMolecular weight:293.15281Clopidogrel Amide ((S)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C15H15ClN2OSColor and Shape:White Off-White SolidMolecular weight:306.059362-Oxo Clopidogrel (Mixture of Diastereomers) (methyl 2-(2-chlorophenyl)-2-(2-oxo-2,6,7,7a-tetrahydrothieno[3,2-c]pyridin-5(4H)-yl)acetate)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C16H16ClNO3SColor and Shape:Off-White SolidMolecular weight:337.05394Clopidogrel Piperidinylidene Analog ((E)-2-(1-(1-(2-chlorophenyl)-2-methoxy-2-oxoethyl)-4-((2-(3-methoxyphenyl)-2-oxoethyl)thio)piperidin-3-ylidene)acetic acid)
Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C25H26ClNO6SColor and Shape:Pale Yellow SolidMolecular weight:503.11694Clopidogrel N-Oxide (5-((S)-1-(2-chlorophenyl)-2-methoxy-2-oxoethyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine 5-oxide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C16H16ClNO3SColor and Shape:Pale Yellow SolidMolecular weight:337.05394Allopurinol
CAS:Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFormula:C5H4N4OColor and Shape:White PowderMolecular weight:136.03851Caffeine Related Compound C (1,3,9-Trimethyl-3,9-dihydro-1H-purine-2,6-dione)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C8H10N4O2Color and Shape:White Fine PowderMolecular weight:194.08038Allopurinol Related Compound C (5-(4H-1,2,4-triazol-4-yl)-1H-pyrazole-4-carboxamide)
CAS:Compounds containing an unfused pyrazole ring, whether or not hydrogenated, in the structure, nesoiFormula:C6H6N6OColor and Shape:White Off-White Crystalline PowderMolecular weight:178.06031

